A Phase I/II Dose Escalation Study to Evaluate Pain Response Using Extracranial Stereotactic Radiosurgery to Treat Paraspinal Metastasis in Patients Who Have Received Prior Spinal Irradiation
The goal of the study is to determine the lowest dose of radiation that can be given to
effectively control the tumor and provide effective pain relief.
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
To determine the optimal dose of stereotactic spinal irradiation needed to obtain durable pain control at 4 weeks in a previously irradiated spine field.
Jeffrey Bradley, M.D.
Washington University School of Medicine
United States: Institutional Review Board
|Washington University||St. Louis, Missouri 63110|